News Briefs

FiveThirtyEight: the COVID-19 metrics policymakers should be watching after Omicron
February 6, 2022 - 12:55 pm

The COVID-19 pandemic has brought up tons of data questions — what information should we be collecting, what can it tell us (and what does it fail to tell us) and how should the data we use to make decisions be communicated to the public? We’ve started a new series, “COVID Convos,” that brings these questions to the forefront through interviews with the scientists and practitioners who produce and use data on COVID-19.

Each conversation will be a chance for a different scientist to highlight a dataset or data question they think is particularly important and tell us why. We’re kicking things off with Tim Lahey, an infectious disease physician and the head of ethics at the University of Vermont Medical Center. Our discussion focused on the metrics society uses to decide how — and when — to respond to COVID.

Source: FiveThirtyEight

The COVID-19 Metrics Policymakers Should Be Watching After Omicron

News Briefs


The Fight Over Inoculation During the 1721 Boston Smallpox Epidemic
The Fight Over Inoculation During the 1721 Boston Smallpox Epidemic

Although inoculations were themselves a risky practice and carried a not-insignificant health risk, this data demonstrates that inoculations were significantly less fatal than the naturally occurring virus.

Twitter Handle

Copyright © 2022 I Daily Remedy